Bailing Capsule Efficacy and Safety for Adult Nephrotic Syndrome: Meta-Analysis of 11 RCTs

A systematic review and meta-analysis of 11 randomized controlled trials involving 920 adult patients with primary nephrotic syndrome. The study evaluates the efficacy and safety of Bailing Capsule, a traditional Chinese medicinal preparation, on renal function and immune markers. The document was authored by Muyuan Guo and uploaded to figshare in April 2026.

Use Cases

• Assessing the effect of Bailing Capsule on 24-hour urinary protein excretion (24hUpro) based on the described meta-analysis results.
• Evaluating changes in serum creatinine (Scr) and blood urea nitrogen (BUN) levels from adjunctive therapy based on the study findings.
• Analyzing the impact on immune function markers like CD3+ and CD4+ T lymphocytes based on the reported outcomes.
• Reviewing the safety profile and adverse event incidence of a traditional Chinese medicine for nephrotic syndrome based on the systematic review.

Strengths

• Analysis is based on 11 randomized controlled trials, a defined study design.
• Includes data from 920 adult patients, providing a specific sample size.
• Systematically searched eight major databases up to December 20, 2025, indicating a defined search methodology.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is a 17.7 KB document, indicating a very limited scope focused on summary results rather than raw trial data.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of randomized controlled trials from eight databases.

Time Range

Literature search from database inception to December 20, 2025.

Freshness

Last updated 2026-04-24 05:40:20; freshness should be verified.